Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.24 EUR | -0.18% | -2.46% | -3.17% |
05-31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
05-31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
54.63B | - | |||||
39.92B | ||||||
38.82B | ||||||
26.86B | ||||||
26.22B |